Privium Fund Management
VRTX icon

Privium Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Privium Fund Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-9,400
Closed -$4.67M – 67
2026
Q2 		$4.67M Sell
9,400
-1,955
-17% -$866K 0.86% 24
2026
Q1 		$5.07M Buy
11,355
+2,000
+21% +$933K 1.06% 23
2025
Q4 		$4.24M Buy
9,355
+1,055
+13% +$455K 0.78% 23
2025
Q3 		$3.25M Hold
8,300
– – 0.58% 24
2025
Q2 		$3.75M Hold
8,300
– – 0.81% 18
2025
Q1 		$4.02M Buy
+8,300
New +$3.87M 1.05% 19
2024
Q1 		– Sell
-15,116
Closed -$6.21M – 129
2023
Q4 		$6.21M Sell
15,116
-6,279
-29% -$2.32M 1.73% 19
2023
Q3 		$7.44M Sell
21,395
-9,515
-31% -$3.33M 2.21% 12
2023
Q2 		$10.8M Sell
30,910
-1,560
-5% -$526K 3.1% 9
2023
Q1 		$10.2M Sell
32,470
-2,837
-8% -$851K 3.44% 7
2022
Q4 		$10.2M Buy
35,307
+6,807
+24% +$2.07M 3.87% 9
2022
Q3 		$8.34M Buy
28,500
+500
+2% +$144K 3.03% 9
2022
Q2 		$7.89M Hold
28,000
– – 2.61% 12
2022
Q1 		$7.31M Sell
28,000
-3,000
-10% -$712K 1.62% 19
2021
Q4 		$6.9M Buy
+31,000
New +$6.03M 1.37% 24

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Privium Fund Management's VRTX Position: Q3 2026 in Review

Privium Fund Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 9,400 shares — an estimated $4.67M sold.

Privium Fund Management first reported a position in VRTX in Q4 2021 and held it in 15 quarters. The position peaked at $10.8M in Q2 2023. 1,108 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Privium Fund Management reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Privium Fund Management sold 9,400 Vertex Pharmaceuticals shares in Q3 2026, an estimated $4.67M.
  • Privium Fund Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 15 quarters.
  • Privium Fund Management's Vertex Pharmaceuticals position peaked at $10.8M in Q2 2023.
  • 1,108 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Privium Fund Management's 13F filing for Q3 2026, filed 3 Nov 2026.